Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

NRSN NeuroSense Therapeutics

Watchlist
1.690
+0.030+1.81%
Close  01/27 16:00 ET
1.570
-0.120-7.10%
Post Mkt Price 01/27 17:55 ET
High
1.740
Open
1.660
Turnover
176.40K
Low
1.550
Pre Close
1.660
Volume
108.74K
Market Cap
19.73M
P/E(TTM)
Loss
52wk High
8.180
Shares
11.67M
P/E(Static)
Loss
52wk Low
1.075
Float Cap
11.61M
Bid/Ask %
-66.67%
Historical High
8.180
Shs Float
6.87M
Volume Ratio
0.14
Historical Low
1.075
Dividend TTM
--
Div Yield TTM
--
P/B
2.51
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.58%
Amplitude
11.45%
Avg Price
1.622
Lot Size
1
Float Cap
11.61M
Bid/Ask %
-66.67%
Historical High
8.180
Shs Float
6.87M
Volume Ratio
0.14
Historical Low
1.075
Dividend TTM
--
P/B
2.51
Dividend LFY
--
Turnover Ratio
1.58%
Amplitude
11.45%
Avg Price
1.622
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company. The firm is focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. It is involved in the 2b/3 clinical trial using its product candidate, PrimeC in patients with ALS and also commencing research into other possible indications for the drug, including Alzheimer’s and Parkinson’s diseases. The company was founded by Alon Ben-Noon on February 13, 2017 and is headquartered in Herzliya, Israel.
CEO: Mr. Alon Ben-Noon
Market: NASDAQ
Listing Date: 12/09/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist